Loading…
PETNET Solutions Inc., a pharmaceutical drug manufacturer, received an FDA Warning Letter on October 17, 2019, indicating significant regulatory compliance concerns. While the specific violations cannot be detailed due to unavailable subject line information and limited metadata, the letter indicates deficiencies related to drug manufacturing or distribution practices under FDA oversight. This warning represents a formal enforcement action that required the company to take corrective measures to meet federal drug manufacturing and quality standards.